Hiroki Izumi
- Co-authors
- Eiji ShimizuToshinori AndoJ. Silvio GutkindYusuke GotoAkira YamasakiZhiyong WangMara GilardiNadia Arang
- Topics
- Lung Cancer Treatments and Mutations (23 papers)Lung Cancer Research Studies (22 papers)Cancer therapeutics and mechanisms (12 papers)
- Partner nations
- JapanUnited StatesSpain
In The Last Decade
Hiroki Izumi
61 papers receiving 519 citations
Peers
Comparison fields: 5 of 76
- Oncology 251
- Pulmonary and Respiratory Medicine 179
- Molecular Biology 175
- Epidemiology 62
- Immunology 59
Countries citing papers authored by Hiroki Izumi
This map shows the geographic impact of Hiroki Izumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Izumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Izumi more than expected).
Fields of papers citing papers by Hiroki Izumi
This network shows the impact of papers produced by Hiroki Izumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Izumi. The network helps show where Hiroki Izumi may publish in the future.
Co-authorship network of co-authors of Hiroki Izumi
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Izumi. A scholar is included among the top collaborators of Hiroki Izumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Izumi. Hiroki Izumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 22 | |
| 11 | 0 | |
| 12 | 6 | |
| 13 | 1 | |
| 14 | 1 | |
| 15 | 1 | |
| 16 | 1 | |
| 17 | 49 | |
| 18 | 24 | |
| 19 | 2 | |
| 20 | Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia. | 1 |
About Hiroki Izumi
Hiroki Izumi is a scholar working on Microbiology, Oncology and Pulmonary and Respiratory Medicine, having authored 68 papers that have together received 528 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (22 papers) and Cancer therapeutics and mechanisms (12 papers). The work is most often cited by research in Oncology (251 citations), Pulmonary and Respiratory Medicine (179 citations) and Cancer Research (55 citations). Hiroki Izumi has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Eiji Shimizu, Toshinori Ando, J. Silvio Gutkind, Yusuke Goto, Akira Yamasaki, Zhiyong Wang, Mara Gilardi, Nadia Arang, Masahiro Kodani and Xiaodong Feng. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.